BNB Plus Corp. BNBX 深 沪
等待开盘 04-17 09:30:00 美东时间
0.576
-0.035
-5.67%
华盛通- 最 高0.6499
- 今 开0.6289
- 成交量 42.12万股
- 最 低 0.52
- 昨 收 0.6106
- 总市值 326.45万
- 52周最高 13.95
- 市盈率 静 --
- 换手率 7.43%
- 52周最低 0.52
- 委 比 60.92%
- 总股本 566.75万
- 历史最高 6804000.00
- 量 比 0.19
- 振 幅 21.27%
- 历史最低 0.52
- 每 手 1
- 风险率 3.28%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股夜盘 | NextNRG涨28.29%，BNB Plus Corp.涨25.17%
NextNRG涨28.29%；BNB Plus Corp.涨25.17%；Immutep Ltd Sponsored ADR涨21.98%
04-15 15:01
美股夜盘 | NextNRG涨29.88%，NN, Inc.涨25.48%
NextNRG涨29.88%；NN, Inc.涨25.48%；Immutep Ltd Sponsored ADR涨21.98%
04-15 13:01
美股夜盘 | NextNRG涨30.02%，Immutep Ltd Sponsored ADR涨21.98%
NextNRG涨30.02%；Immutep Ltd Sponsored ADR涨21.98%；BNB Plus Corp.涨16.55%
04-15 10:01
美股夜盘 | NextNRG涨32.09%，Immutep Ltd Sponsored ADR涨21.98%
NextNRG涨32.09%；Immutep Ltd Sponsored ADR涨21.98%；BNB Plus Corp.涨16.43%
04-15 09:01
美股夜盘 | NextNRG涨36.06%，BNB Plus Corp.涨17.23%
Arrive AI涨-26.67%；HeartBeam涨-14.17%；Ambitions Enterprise Management涨-13.64%
04-15 08:10
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers BNB Plus (NASDAQ:BNBX) stock moved upwards by 12.7% to $0.65 during Tu...
04-15 05:05
BNB Plus' Subsidiary Granted Patent By European Patent Office For Application 21882234.4 Entitled Compositions and Methods for RNA Synthesis
BNB Plus Corp. (Nasdaq: BNBX) ("BNBX" or the "Company"), announced today that its biopharmaceutical subsidiary, LineaRx, Inc. ("LineaRx"), has been granted a European patent by the European Patent Office (EPO) related to
03-18 20:05
BNB Plus Corp's LineaRx secures two new LineaDNA orders from genetic medicine developers
BNB Plus Corp's LineaRx secures two new LineaDNA orders from genetic medicine developers BNB Plus Corp. said its biopharmaceutical subsidiary, LineaRx, received two new orders for LineaDNA from developers of genetic medicines. The company expects production and shipment of both orders to be complete
02-24 20:01
BNB Plus Q1 EPS $(2.08) Up From $(420.00) YoY, Sales $565.394K Down From $1.197M YoY
BNB Plus (NASDAQ:BNBX) reported quarterly losses of $(2.08) per share. This is a 99.5 percent increase over losses of $(420.00) per share from the same period last year. The company reported $565.394 thousand in sales
02-13 06:30
